HN2002000312A - BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS - Google Patents

BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS

Info

Publication number
HN2002000312A
HN2002000312A HN2002000312A HN2002000312A HN2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A HN 2002000312 A HN2002000312 A HN 2002000312A
Authority
HN
Honduras
Prior art keywords
formulations
antagonist activity
linear compounds
basic linear
compounds
Prior art date
Application number
HN2002000312A
Other languages
Spanish (es)
Inventor
Sisto Alessandro
Caciagli Valerio
Altamura Maria
Giolitti Alessandro
Fedi Valentina
Guidi Antonio
Giannotti Danilo
Harmat Nicholas
Nannicini Rossano
Pasqui Franco
Alberto Maggi Carlo
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of HN2002000312A publication Critical patent/HN2002000312A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a compuestos antagonistas de taquiquinas en general, y en modo general, y en modo particular de la neuroquina A, y a su empleo en formulaciones farmacéuticas. Las Taquiquininas constituyen una familia que incluye, como mínimo, tres péptidos que son conocidos como sustancia P, Neuroquinina A (NKA) Y Neuroquinina B (NKB). En la presente se describen los compuestos de la fórmula (I) que resultan de utilidad como antagonistas de taquininas en general, y en particular de la neuroquinina A; y las formulaciones que comprenden los compuestos de la fórmula (I)The present invention relates to antagonist compounds of tachykin in general, and in general, and in particular of neurokine A, and their use in pharmaceutical formulations. Tachykinins are a family that includes at least three peptides that are known as substance P, Neurokinin A (NKA) and Neurokinin B (NKB). The compounds of formula (I) that are useful as antagonists of takinins in general, and of neurokinin A in particular, are described herein; and formulations comprising the compounds of formula (I)

HN2002000312A 2001-10-29 2002-10-28 BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS HN2002000312A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI20010203 ITFI20010203A1 (en) 2001-10-29 2001-10-29 LINEAR COMPOUNDS WITH BASIC CHARACTERISTICS WITH ACTIVITY NK-2 ANTAGONIST, THEIR SYNTHESIS PROCESSES AND FORMULATIONS THAT CONTAIN THEM

Publications (1)

Publication Number Publication Date
HN2002000312A true HN2002000312A (en) 2005-12-20

Family

ID=27620690

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000312A HN2002000312A (en) 2001-10-29 2002-10-28 BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS

Country Status (2)

Country Link
HN (1) HN2002000312A (en)
IT (1) ITFI20010203A1 (en)

Also Published As

Publication number Publication date
ITFI20010203A1 (en) 2003-04-29

Similar Documents

Publication Publication Date Title
PA8548401A1 (en) ANTIBACTERIAL AGENTS
PL420160A1 (en) Veterinary antiparasitic oral compositions, that include systemically acting active substances, methods and applications covering them
CY1109010T1 (en) c-crystalline form of hydrochloride ivabradine, its preparation method and the pharmaceutical compositions containing it
CY1110262T1 (en) Substituted Pepperidine Compounds for Use as H3 receptor antagonists
UY27729A1 (en) QUINASE INHIBITORS.
UY28572A1 (en) NEW COMPOUNDS
UY28906A1 (en) PIRIMIDINE DERIVATIVES THAT ARE ANTAGONISTS OF THE VITRONECTINE RECEPTOR
ITMI20050328A1 (en) PEPTIDOMIMETRIC COMPOUNDS AND PREPARATION OF BIOLOGICALLY ACTIVE DERIVATIVES
CY1108797T1 (en) A-CRYSTAL FORM OF RANELIC STRONTIUM, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
EA200701065A1 (en) INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine
GT200700096A (en) PIRAZOLINE COMPOUNDS
CY1105847T1 (en) LINEAR BASIC COMPOUNDS EXHIBITING NK-2 ANTAGONIST ACTIVITY AND PREPARATION THEREOF
NO20063393L (en) Pharmaceutical preparations
PA8553701A1 (en) ANTIDIABETIC AGENTS
CY1123382T1 (en) ORAL AND INJECTABLE AND PREPARATION OF TETRACYCLINE COMPOUNDS
UY27851A1 (en) DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE.
UY28247A1 (en) BENZOPIRAN COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF AFFECTIONS RELATED TO INFLAMMATION.
HN2002000312A (en) BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS
BRPI0417205A (en) pharmaceutical compositions
DE60322110D1 (en) SUBSTITUTED 4- (4-PIPERIDIN-YL-PIPERAZIN-1-YL) -AZNTAGONISTS
DE602004014285D1 (en) ABIOTIC HEPARIN ANTAGONISTS
DOP2002000386A (en) ANTIBACTERIAL AGENTS
CY1108865T1 (en) Substituted 2,5-diaminobutyl-1H-pyrroles
DE602005011314D1 (en) 4-HYDROXYTAMOXIFENGEL FORMULATIONS
UY31541A1 (en) 1 (2) H-TETRAZOL-5-IL-FENIL-OXAZOLIDINONA S AS ANTIBACTERIAL AGENTS